Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Left ventricular remodelling in asymptomatic HIV infection on chronic HAART: comparison between hypertensive and normotensive subjects with and without HIV infection

Journal of Human Hypertension volume 26, pages 570–576 (2012)Cite this article

Subjects

Abstract

The high cardiovascular risk of HIV infected (HIV+) patients is still partly unexplained. We aimed to evaluate if HIV infection and highly active antiretroviral therapy (HAART) are linked per se to left ventricular (LV) remodelling, independently of blood pressure (BP) values. We enrolled 4 groups of patients matched by gender, age, body mass index and smoking habit: 30 HIV+ hypertensives, 30 HIV+ normotensives, 30 not-infected (HIV−) hypertensives and 30 HIV− normotensives. HIV+ patients were on chronic HAART. Hypertension was newly diagnosed (⩽6 months) and never treated. Each patient underwent blood tests, 24-h BP monitoring and LV echocardiogram. The 4 groups had similar fasting glucose and cholesterol; triglycerides, HOMA index and prevalence of metabolic syndrome were higher in the HIV+ groups. Despite similar 24-h BP values, HIV+ hypertensives had greater LV mass and higher prevalence of preclinical diastolic dysfunction than HIV− hypertensives. Compared to HIV− normotensives, HIV+ normotensives had similar 24-h BP values, but greater LV mass and lower LV diastolic indices, similar to HIV− hypertensives, whose 24-h BP values were higher. Asymptomatic HIV infection and chronic HAART are associated with myocardial hypertrophy and preclinical diastolic dysfunction, independently of BP values.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Palella F, Delaney K, Moorman A, Palella Jr FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853–860.

    Article  Google Scholar 

  2. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008; 118: e29–e35.

    Article  CAS  Google Scholar 

  3. Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P et al. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risks factors. Circulation 2008; 118: e20–e28.

    Article  CAS  Google Scholar 

  4. Dubé MP, Lipshultz SE, Fichtenbaum CJ, Greenberg R, Schecter AD, Fisher SD et al. Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation 2008; 118: e36–e40.

    Article  Google Scholar 

  5. Ho JE, Hsue PY . Cardiovascular manifestations of HIV infection. Heart 2009; 95: 1193–1202.

    Article  Google Scholar 

  6. Jerico C, Knobel H, Montero M, Sorli ML, Guelar A, Gimeno JL et al. Hypertension in HIV-infected patients: prevalence and related factors. Am J Hypertens 2005; 18: 1396–1401.

    Article  Google Scholar 

  7. Baekken M, Os I, Sandvik L, Oektedalen O . Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens 2008; 26: 2126–2133.

    Article  CAS  Google Scholar 

  8. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.

    Article  CAS  Google Scholar 

  9. Schillaci G, Pasqualini L, Verdecchia P, Vaudo G, Marchesi S, Porcellati C et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002; 39: 2005–2011.

    Article  Google Scholar 

  10. Stein JH, Hadigan CM, Brown TT, Chadwick E, Feinberg J, Friis-Moller N et al. Prevention strategies for cardiovascular disease in HIV-infected patients. Circulation 2008; 118: e54–e60.

    Article  Google Scholar 

  11. Grinspoon SK . Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med 2005; 118 (Suppl 2): 23–28.

    Google Scholar 

  12. Lauer MS, Anderson KM, Kannel WB, Levy D . The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991; 266: 231–236.

    Article  CAS  Google Scholar 

  13. Grandi AM, Zanzi P, Fachinetti A, Gaudio G, Ceriani L, Bertolini A et al. Insulin and diastolic dysfunction in lean and obese hypertensives. Genetic influence. Hypertension 1999; 34: 1208–1214.

    Article  CAS  Google Scholar 

  14. De las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007; 28: 553–559.

    Article  Google Scholar 

  15. Sundstrom J, Arnlov J, Stolare K, Lind L . Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study. Heart 2008; 94: 874–878.

    Article  CAS  Google Scholar 

  16. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C et al. Metabolic syndrome in the Pressione Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage and prognosis. Hypertension 2007; 49: 40–47.

    Article  CAS  Google Scholar 

  17. Coudray N, de Zuttere D, Force G, Champetier de Ribes D, Pourny JC et al. Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 1995; 16: 61–67.

    Article  CAS  Google Scholar 

  18. Barbaro G, Barbarini G, Di Lorenzo G . Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: a multicenter echocardiographic and echo-Doppler study. AIDS Res Hum Retrov 1996; 12: 1559–1562.

    Article  CAS  Google Scholar 

  19. Longo-Mbenza B, Seghers LV, Vita EK, Tonduangu K, Bayekula M . Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study. Heart 1998; 80: 184–189.

    Article  CAS  Google Scholar 

  20. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Rocha Gonçalves F, Lecour H . Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol 1998; 63: 37–45.

    Article  CAS  Google Scholar 

  21. Martínez-García T, Sobrino JM, Pujol E, Galvez J, Benítez E, Girón-González JA . Ventricular mass and diastolic function in patients infected by the human immunodeficiency virus. Heart 2000; 84: 620–624.

    Article  Google Scholar 

  22. Umana E, Panayiotou H, Ramsey KA, Bikkina M, Massey CV, Alpert MA . Left ventricular mass and systolic function in human immunodeficiency virus-infected patients after weight loss. Am J Cardiol 2000; 86: 1040–1043, A11.

    Article  CAS  Google Scholar 

  23. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee S et al. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 2002; 30: 306–310.

    Article  CAS  Google Scholar 

  24. Mansoor A, Golub ET, Dehovitz J, Anastos K, Kaplan RC, Lazar JM . The association of HIV infection with left ventricular mass/hypertrophy. AIDS Res Hum Retroviruses 2009; 25: 475–481.

    Article  CAS  Google Scholar 

  25. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  PubMed  Google Scholar 

  26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  Google Scholar 

  27. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  Google Scholar 

  28. Devereux RB, Reichek N . Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.

    Article  CAS  Google Scholar 

  29. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251–1260.

    Article  CAS  Google Scholar 

  30. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiogaphy 2006; 7: 79–108.

    Article  Google Scholar 

  31. Grandi AM, Venco A, Barzizza F, Casadei B, Marchesi E, Finardi G . Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 1989; 63: 1093–1097.

    Article  CAS  Google Scholar 

  32. Fagard RH, Celis H, Thijs L, Wouters S . Regression of left ventricular mass by antihypertensive treatment. A meta-analysis of randomized comparative studies. Hypertension 2009; 54: 1084–1091.

    Article  CAS  Google Scholar 

  33. Strazzullo P, Kerry SM, Barbato A, Versiero M, D’Elia L, Cappuccio FP . Do statins reduce blood pressure? A meta-analysis of randomized, controlled trials. Hypertension 2007; 49: 792–798.

    Article  CAS  Google Scholar 

  34. Ge CJ, Lu SZ, Chen YD, Wu XF, Hu SJ, Ji Y . Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodelling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Heart Vessels 2008; 23: 91–95.

    Article  Google Scholar 

  35. Payne JR, James LE, Eleftheriou KI, Hawe E, Mann J, Stronge A et al. The association of left ventricular mass with blood pressure, cigarette smoking and alcohol consumption; data from the LARGE Heart study. Int J Cardiol 2007; 120: 52–58.

    Article  Google Scholar 

  36. Chiolero A, Faeh D, Paccaud F, Cornuz J . Consequences of smoking for body weight, body fat distribution and insulin resistance. Am J Clin Nutr 2008; 87: 801–809.

    Article  CAS  Google Scholar 

  37. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the management of arterial hypertension. J Hypertens 2007; 25: 1751–1762.

    Article  CAS  Google Scholar 

  38. Todd Cade W . Left ventricular dysfunction in human immunodeficiency virus infection. J Cardiometab Syndr 2008; 3: 83–87.

    Article  Google Scholar 

  39. Tokudome T, Horio T, Yoshihara F, Suga S, Kawano Y, Kohno M et al. Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts. Metabolism 2004; 53: 710–715.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, University of Insubria, Ospedale di Circolo, Varese, Italy

    A M Grandi, E Nicolini, M Giola, M Gianni, A M Maresca, C Marchesi, L Guasti, M L Balsamo, A Venco & P A Grossi

Authors
  1. A M Grandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Nicolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Giola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Gianni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A M Maresca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C Marchesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L Guasti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M L Balsamo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Venco
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P A Grossi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A M Grandi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grandi, A., Nicolini, E., Giola, M. et al. Left ventricular remodelling in asymptomatic HIV infection on chronic HAART: comparison between hypertensive and normotensive subjects with and without HIV infection. J Hum Hypertens 26, 570–576 (2012). https://doi.org/10.1038/jhh.2011.81

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2011.81

Keywords

This article is cited by

Search

Advanced search

Quick links